Essex Woodlands Health Ventures

Latest statistics and disclosures from Essex Woodlands Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BVS, TELA, EYPT, RVNC, MNOV, and represent 98.12% of Essex Woodlands Management's stock portfolio.
  • Added to shares of these 1 stock: Venus Concept.
  • Reduced shares in these 1 stock: EYPT (-$5.6M).
  • Essex Woodlands Management was a net seller of stock by $-5.6M.
  • Essex Woodlands Management has $113M in assets under management (AUM), dropping by -14.15%.
  • Central Index Key (CIK): 0001542339

Tip: Access up to 7 years of quarterly data

Positions held by Essex Woodlands Health Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Essex Woodlands Management

Essex Woodlands Management holds 6 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bioventus Com Cl A (BVS) 37.9 $43M 13M 3.30
 View chart
Tela Bio (TELA) 29.0 $33M 4.1M 8.00
 View chart
Eyepoint Pharmaceuticals Com New (EYPT) 24.6 $28M -16% 3.5M 7.99
 View chart
Revance Therapeutics (RVNC) 4.6 $5.2M 457k 11.47
 View chart
Medicinova Com New (MNOV) 2.0 $2.3M 1.1M 2.09
 View chart
Venus Concept 1.9 $2.1M 1.1M 1.96
 View chart

Past Filings by Essex Woodlands Management

SEC 13F filings are viewable for Essex Woodlands Management going back to 2011

View all past filings